lotilaner

DRUG2 trials

Sponsors

LianBio LLC, Tarsus Pharmaceuticals, Inc.

Conditions

BlepharitisOcular Rosacea

Phase 2

Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)

Enrolling by invitationNCT07443202

Tarsus Pharmaceuticals, Inc.Ocular Rosacea

Start: 2025-12-05End: 2027-12-31Target: 155Updated: 2026-03-02

Phase 3

Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

CompletedNCT05629390

LianBio LLCBlepharitis

Start: 2022-10-23End: 2024-04-02Updated: 2024-05-21